title: [Drug therapy of chronic heart failure].
abstract: Prevention of disease leading to cardiac dysfunction, improvement of quality of life and reduction of mortality are the primary objectives in the treatment of chronic heart failure. The therapeutic possibilities are various, including general advices, pharmacological therapy and surgical interventions. Standard medical treatment of systolic cardiac dysfunction contains ACE inhibitors, diuretics and cardiac glycosides. Beta-blocking agents, oral anticoagulation and antiarhythmic drugs can be used in addition. A therapeutic management of chronic heart failure tailored to the individual patient has nowadays become available due to multiple treatment options.
authors.affiliation: Abteilung für Kardiologie, Medizinischen Universitätsklinik Graz. norbert.watzinger@kfunigraz.ac.at
authors.forename: N
authors.initials: N
authors.lastname: Watzinger
authors.forename: F M
authors.initials: FM
authors.lastname: Fruhwald
authors.forename: W
authors.initials: W
authors.lastname: Klein
mesh_terms: D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D011379:Prognosis; D011788:Quality of Life
chemical_list: D002317:Cardiovascular Agents
vernacular_title: Medikamentöse Therapie der chronischen Herzinsuffizienz.